Epidiolex derived from marijuana to treat epilepsy
The U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with two rare and severe forms of
Childhood epilepsy
Ethosuximide is preferred for childhood epilepsy
Comparative effectiveness trial leads to evidence-based care for childhood epilepsy – The first comprehensive comparative effectiveness clinical trial of three widely used anti-seizure drugs for childhood absence epilepsy ? the most common form of epilepsy in kids ? has established an evidence-based approach for initial drug therapy.
Potential drugs for mental retardation and autism treatment
US researchers say they have successfully corrected key symptoms of a type of autism and mental retardation in mice, a development which could offer sufferers a potential treatment. – Researchers at MIT’s Picower Institute for Learning and Memory have corrected key symptoms of mental retardation and autism in mice. The work, which will be reported in the Dec. 20 issue of Neuron, indicates that a certain class of drugs could have the same effect in humans. These drugs are not yet approved by the FDA, but will soon be entering into clinical trials.